In human gastric cancers, MDSCs are increased in circulation (41) and cancer tissue (42), and they significantly correlate with plasma levels of calprotectin (S100a8/9) (41), as well as with lower survival rates (41, 42). This evidence concerns the gene S100A8 and gastric cancer.